Primary tumor tissue from patients with metastatic disease at diagnosis exhibited greater LAT-1 (Figure 4a) and GLUT-1 (Figure 4b) expression and lower pVHL (Figure 4c) expression compared to tumors from patients with non-metastatic disease at diagnosis. Here, SLC2A1 is linked to metastatic neoplasm.